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Table 1: Guideline data collection 
Guideline table Arguments Key 
Guideline number  Numerical number to allocate the guideline. Numerical number 
Filenames File name of the record. e.g. “G0001.csv” 
Guideline name  Identity of the guideline. Copy the guideline name from the guideline 
Guideline disease  Disease where the recommendations are made for. Copy the disease 
Name of the guideline institution Guideline institution who wrote the guideline.   Copy the guideline institution’s name 
Category of the guideline 
institution  
Category institution who wrote the guideline.   0 = industry 
1 = HTA 
2 = NICE 
3 = SIGN 
4 = SIGN + other body 
5 = professional body (e.g. RCPCH / BTS) 
6 = NICE + other body 
7 = other 
Funding Mentioned funder in the guideline  0 = unclear, not mentioned 
1 = industry 
2 = government 
3 = foundation 
4 = other 
5 = not externally funded 
Date of guideline publication  Date of guideline publications Month and year of publication. E.g. “Dec-11”  
Review date Date the guideline is/will be reviewed 0 = unclear update time  
Review date in time in years after first publication. 
Update time mentioned in the 
guideline 
Time period for the guideline to be updated given in the 
guideline.  
0 = unclear update time  
Update time in years. 
Number of recommendations  Number of recommendations made in the guideline  Number of recommendations 
Number of recommendations 
included 
Number of recommendations made in the guideline 
which included in the research 
Number of included recommendations 
Methodology used in the 
guideline 
Methodology used by the guideline.  Copy the used methodology 
URL For quick access to the guideline. Copy the URL 
Comment Place for making a comment if necessary  Type the comment 
Accessibility of declarations of 
interest 
How easy it is to get access to the declarations of 
interest. 
1= impossible; not available or not mentioned 
2 = very difficult; after requesting still difficult to get access 
3 = difficult; available after requesting 
4 = intermediate; accessible on the website 
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5 = easy; in the guideline 
Completeness of declarations 
of interest 
How complete the declarations of interest are. E.g. only 
mentioned that there is no conflict of interest or per 
person mentioned what the work functions are. 
1 = not available 
2 = unknown because difficult to access 
3 = unspecified 
4 = specified what conflicts are 
5 = specified per person what all work functions are 
Conflict of interest If there is a conflict of interest 0 = unknown 
1 = yes 
2 = no 
Grading Methodology used for grading the evidence used in the 
guideline 
0 = Unknown 
1 = SIGN 
2 = AHCPCR, 1992 
3 = GRADE (Grading of Recommendations Assessment, 
Development and Evaluation system) 
4 = HTA report 
5 = Other 
Level of evidence per 
recommendation known 
If the level of evidence per recommendation is given in 
the guideline 
0 = Inapplicable 
1 = Yes 
2 = No 
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Table 2: Guideline recommendation data collection 
Guideline table Arguments Key 
Guideline name  To identify the 
guideline. 
Copy the guideline name from the master table of guidelines 
Guideline number To refer to the 
guideline 
Copy the guideline number from the master table of guidelines 







made in the 
guideline. 









To easily find the 
recommendation 
0 =  inapplicable 
Copy the page of recommendation 
Paragraph of 
recommendation 
To easily find the 
recommendation 
Copy the paragraph of recommendation 
Recommendation  Recommendation 
made in the 
guideline 







0 = included 
1 = excluded 
Level of evidence  Use SIGN 
methodology to 
determine the 
reliability of the 
recommendation. 
0 = level of evidence unclear 
SIGN methodology 
1++ = High quality meta-analyses, systemic reviews of RCTs, or RCTs with a very low risk of bias. 
1+ = Well conducted meta-analyses, systemic reviews, or RCTs with a low risk of bias. 
1- = Meta-analyses, systemic reviews, or RCTs with a low risk of bias. 
2++ = High quality systematic reviews of case control or cohort studies. High quality case control or 
cohort studies with a very low risk of confounding or bias and a high probability that the relationship 
is causal. 
2+ = Well conducted case control or cohort studies with a low risk of confounding or bias and a 
moderate probability that the relationship is causal. 
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2- = Case control or cohort studies with a high risk of confounding or bias and a significant risk that the 
relationship is not causal 
3 = Non-analytical studies, eg case reports, case series 
4 = Expert opinion 
 
Converting GRADE methodology to SIGN methodology: 




Very low 4 
 
Converting AHCPR methodology to SIGN methodology: 
Level of evidence AHCPR methodology Converted to 
SIGN 
methodology 
A: Requires at least one randomised controlled trial as part of the body of literature of overall 
good quality and consistency addressing the specific recommendation. 
1 | 2++ 
B: Requires availability of well conducted clinical studies but no  
randomised clinical trials on the topic of the recommendation. 
2 | 3 
C: Requires evidence from expert committee reports or opinions and/or clinical experience of 
respected authorities. Indicates absence of directly applicable studies of good quality. 
3 | 4 
 
Converting level of evidence used in the BTS guideline: Guidelines for the 
management of community acquired pneumonia in children, to SIGN methodology: 
 
Level of evidence BTS methodology Converted to SIGN 
methodology 
A+: A good recent systematic review of studies designed to 
answer the question of interest 
1 | 2 
A-: One or more rigorous studies designed to answer the 
question, but not formally combined 
2 
B+: One or more prospective clinical studies which illuminate, 
but do not rigourisly answer, the question 
2 
B-: One or more retrospective clinical studies which illuminate, 
but do not rigoursly answer, the question 
2 
C: formal combination of expert views 4 
D: other information 4 
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Converting BTS methodology to SIGN methodology when using SIGN methodology but 
only given A/B/C/D: (guidelines for non-CF bronchiectasis / RCPCH: standards for 
services for children with disorders of sleep/ RCPCH: A clinical guideline for the 
management of children presenting with acute breathing difficulty 
 
Level of evidence BTS methodology Converted to SIGN methodology 
A 1 ++ | 1+ 
B 1 | 2 
C 2 
D 3 | 4 
 
 
Converting level of evidence of the BTS guideline: management of opportunist 
mycobacterical infections, to SIGN methodology: 
 
Level of evidence BTS methodology Converted to SIGN 
methodology 
A: Requires at least one randomised controlled trial as part of the 
body of literature of overall good quality and consistency addressing 
the specific recommendation. 
1 | 2++ 
B: Requires availability of well conducted clinical studies but no 
randomised clinical trials on the topic of recommendation. 
2 
C: Requires evidence from expert committee reports or opinions 
and/or clinical experience of respected authorities, but indicates 
absence of directly applicable studies of good quality. 
3 | 4 
 
X = recommendation excluded 
 
Decision for the 
level of evidence 
Who specified the 
level of evidence  
0 = level of evidence specified by the guideline 
1 = level of evidence specified by us 
2 = level of evidence unclear 
 






reliability of the 
recommendation. 
0 = grade of recommendation unclear 
SIGN methodology 
A = At least one meta-analysis, systematic review, or RCT rated as 1++,and directly applicable to 
the target population; or A body of evidence consisting principally of studies rated as 1+,directly 
applicable to the target population, and demonstrating overall consistency of results. 
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B = A body of evidence including studies rated as 2++, directly applicable to the target population, 
and demonstrating overall consistency of results; or Extrapolated evidence from studies rated 
as 1++ or 1+ 
C = A body of evidence including studies rated as 2+,directly applicable to the target population and 
demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 
2++. 
D = Evidence level 3 or 4; or Extrapolated evidence from studies rated as 2+ 
   
Converting GRADE methodology to SIGN methodology: 




Very low D 
 
 
Converting AHCPR methodology to SIGN methodology: 
Level of evidence AHCPR 
methodology 
Converted to SIGN methodology 
A A | B 
B B | C 
C  D 
 
Converting BTS methodology to SIGN methodology: 
Level of evidence BTS methodology Converted to SIGN 
methodology 
A+: A good recent systematic review of studies designed to answer the question 
of interest 
A | B 
A-: One or more rigorous studies designed to answer the question, but not 
formally combined 
B | C 
B+: One or more prospective clinical studies which illuminate, but do not rigourisly 
answer, the question 
B | C 
B-: One or more retrospective clinical studies which illuminate, but do not rigoursly 
answer, the question 
B | C 
C: formal combination of expert views D 
D: other information D 
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Converting level of evidence of the BTS guideline: management of opportunist mycobacterical infections, 
to SIGN methodology: 
 
Level of evidence BTS methodology Converted to SIGN 
methodology 
A: Requires at least one randomised controlled trial as part of the body of literature of 
overall good quality and consistency addressing the specific recommendation. 
A | B  
B: Requires availability of well conducted clinical studies but no randomised clinical trials 
on the topic of recommendation. 
B | C 
C: Requires evidence from expert committee reports or opinions and/or clinical 
experience of respected authorities, but indicates absence of directly applicable studies 
of good quality. 
D 
 
X = recommendation excluded 
Decision for the 
grades of 
recommendation 
Who specified the 
level of evidence 
0 = grade of recommendation specified by the guideline 
1 = grade of recommendation specified by us 
2 = grade of recommendation unclear 
 
X = recommendation excluded 
Patient’s age Age of the patients 
the 
recommendation 
is made for.  
0= inapplicable  
Age in years e.g. 4 – 8.5 
 
Baby: 0-1 
Neonate: 0- 1/12 
 





E.g. Acute asthma 
versus chronicle 
asthma. 
0 = inapplicable 
1 = pregnant 
2 = smoking 
3 = symptomatic 
4 = mild 
5 = moderate 
6 = severe 
7 = life threatening 
8 = breastfeeding 
9 = other 
10 = acute  
11= chronic 
Version	  3.2	  	   05-­‐09-­‐2012	   16	  
 
12 = parents 
 
X = recommendation excluded 
Moment of 
therapy 
At which moment 
of therapy the 
intervention starts. 
0 = inapplicable 
1 = starting 
2= stepping up 
3 = maintenance 
4 = stepping down 
5 = exacerbations 
6 = continue 
7 = add on 
 






0 = avoidance 
1 = nutritional/herbal 
2 = exercise/physiotherapy 
3 = prevention 
4 = pharmacological 
5 = surgical 
6 = weight reduction 
7 = quit smoking 
8 = other 
9 = supporting tool 
10 = referral to specialist 
11 = educational/informational 
12 = psychotherapy  
13 = hospitalisation 
14 = type of device 
 
X = recommendation excluded 
Effective 
intervention 
If an intervention is 
effective or not 
0 =  effective/recommended 
1 =  not effective/ not recommended 
2 = intervention not more or less favoured over one other/insufficient evidence to make a choice  
 
X = recommendation excluded 
Specific medicine Medicine 
recommended  
0= inapplicable  
Copy the name of the medicine recommended 
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X = recommendation excluded 
Main group of the 
medicine 
Main group of the 
recommended 
medicine  
0= inapplicable  
 
Copy the name and number of the main group of the medicine from the table. If the medicine is not mentioned in 
the table: put the name and number of the main group (See BNF for children) in the table and copy from the table. 
 
Main group of the medicine Number of the main group of the 
medicine 
Allergen immunotherapy 3.4.2 
Allergic emergencies 3.4.3 
Aminoglycosides  5.1.4 
Anaemias and some other blood disorders 9.1 
Antibacterial drugs 5.1 
Antifibrinolytic drugs and haemostatics 2.11 
Antifungal drugs 5.2 
Antihistamines 3.4.1 
Antimuscarinic bronchodilators 3.1.2 
Antituberculosis drugs 5.1.9 
Antiviral drugs 5.3 
Bronchodilators 3.1 
Cephalosporins, carbapenems, and other beta-lactams 5.1.2 
Compound bronchodilator preparations 3.1.4 
Corticosteroids 6.3 
Cough suppresants 3.9.1 
Cromoglicate and related therapy 3.3.1 
Drugs used in nasal allergy 12.2.1 
Immunoglobulins 14.5 
Inhaled corticosteroids 3.2 





Nasal preparations for infection 12.2.3 
Non-steroidal anti-inflammatory drugs 10.1.1 
Oral glucocorticoid therapy 6.3.2 
Oxygen 3.6 
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Penicillins 5.1.1 
Proton pump inhibitors 1.3.5 
Quinolones 5.1.12 
Selective beta 2 agonists 3.1.1.1 
Skin cleansers, antiseptics, and preparations for promotion of wound 
healing 
13.11 
Some other antibacterials 5.1.7 
Sulphonamides and trimethoprim 5.1.8 
Tetracyclines 5.1.3 
Theophylline 3.1.3 
Topical nasal decongestants 12.2.2 
Vaccines and antisera 14.4 
Vitamins 9.6 
 
X = recommendation excluded 
Number of the 
main group of the 
medicine  
The main group 
recommended for 
intervention can 
be the same while 
the subgroup 
might differ.  
0= inapplicable  
 
Copy the name and number of the main group of the medicine from the table (table can be found at main group of 
the medicine). If the medicine is not mentioned in the table: put the name and number of the main group (See BNF 
for children) in the table and copy from the table. 
 
X = recommendation excluded 
Dosage  Total dose/day of 
the medicine for a 
stated amount of 
weight 
0= inapplicable  
Copy the total dose (mg)/day for a child of 20 kg’s. 
 
X = recommendation excluded 
Date of literature 
search 
A guideline might 
have different 
dates of literature 
search for different 
chapters.  
0 = date not clear 
Copy the date of literature search per recommendation. 
 
X = recommendation excluded 
Title of Cochrane 
Review used 
If a Cochrane 
review was used 
for the 
recommendation 
Title(s) of the used Cochrane reviews 
 




,, Number(s) of the title(s) of the Cochrane reviews. 
 
X = recommendation excluded 














in the Cochrane 
review and the 
guideline. 
0 = inapplicable 
1 = completely/  No evidence in CR but the guideline has to make a recommendation and takes in mind the fifferent 
target group, adverse effects, pharmacovigilance, costs etc.  
2 = partial  
3 = no agreement 





X = recommendation excluded 
Title of Cochrane 
Review could be 
used 
Cochrane review 
relevant to the 
guideline 
Title(s) of the Cochrane reviews that could be used 
 
X = recommendation excluded 
Number of 
Cochrane Review 
could be used 
Cochrane review 
relevant to the 
guideline 
Number(s) of Cochrane reviews that could be used. 
 
X = recommendation excluded 
Comment Place to make a 
comment is there 
is something 
extraordinary 
Type the comment 
 





in the guideline  is 
included 
0 = included  
1 = excluded 
 
Who found the 
Cochrane Review 
If the Cochrane 
Review was 
included in the 
guideline or not 
0 = inapplicable/recommendation excluded 
1 = Guideline linked the Cochrane Review to the recommendation as well (Both). 
2 = Guideline linked the Cochrane Review to the recommendation but we did not (They). 
3 = We linked the Cochrane Review to the recommendation but the guideline did not (We). 
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Table 3: Cochrane Review data collection 
Cochrane Review table Arguments Key 
Cochrane number  Numerical number to allocate the Cochrane 
Review. 
Numerical number 
Filename File name of the record. e.g. “C0001.csv” 
Cochrane title  Identity of the Cochrane Review. Copy the Cochrane Review name from the 
Cochrane Review. 
Cochrane disease  Disease where the recommendations are made 
for. 
Copy the heading used in the Cochrane Library  
Date of publication  Date of Cochrane Review publications Month and year of publication. E.g. “Dec-11”  
Date of first publication Publication date of the first version of the 
Cochrane Review 
Copy the date of “review first published” in the 
Cochrane Review under “history”. 
Number of recommendations  Number of recommendations made in the 
Cochrane Review.  
Number of recommendations 
Clear recommendation If the recommendation is clear or not 0 = (no recommendation possible as) no evaluable 
evidence. Might be a clear recommendation but 
there is no evidence to confirm (e.g. C0282.csv) 
1 = “soft”/partial recommendation: 
recommendation made but more evidence 
necessary to confirm or when “may” is used in the 
recommendation/effective but benefits have to be 
weighed against the risk of side effects/clear 
recommendation but more evidence necessary to 
confirm. 
2 = clear neutral recommendations: no 
significance difference between interventions 
3 = clear positive recommendation 
4 = clear negative recommendation 
5 = clear recommendation (nor positive nor 
negative) 
URL For quick access to the Cochrane Review. Copy the URL 
Comment Place for making a comment if necessary  Type the comment 
Accessed date  Accessed date of the Cochrane Review Accessed date of the Cochrane Review. “e.g. 
03/07/2012”  
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Cochrane Review  table Arguments Key 
Cochrane title  To identify the Cochrane Review. Copy the Cochrane Review name from the master table of 
Cochrane reviews. 
Cochrane number To refer to the Cochrane Review Copy the Cochrane Review number from the master table of 
Cochrane Reviews 
Filename File name of the record. e.g. “C0001.csv” 
Number of recommendations Number of recommendations made in the 
Cochrane Review. 
Number of recommendations 
Recommendation number Numerical number to allocate the 
recommendation. 
Numerical number 
Recommendation  Recommendation made in the Cochrane Review Copy the author’s conclusions form the Cochrane Review  




See Table 2: Guideline recommendation data collection 
Patient’s age 
Subcategory of patients/disease 
Moment of therapy 
Type of intervention 
Specific medicine 
Main group of the medicine 
Number of the main group of the 
medicine 
Dosage 
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Table 5: Cochrane Reviews relevant to the guideline 
 
Cochrane Reviews and Guidelines linking table Arguments Key 
Name of guideline To identify the guideline. Copy the guideline name from the master table of 
guidelines 
Number of guideline To refer to the guideline Copy the guideline number from the master table 
of guidelines 
File name File name of the record. e.g. “L0001.csv” 
Number Number of the inserted data  e.g. “ 1” 
Title of Cochrane Review referred to in the 
guideline 
Title of Cochrane Review mentioned in the 
references 
Copy the title of the Cochrane Review  
0 =inapplicable 
Number of Cochrane Review referred to in the 
guideline 
Number of Cochrane Review mentioned in the 
references 
Copy the number of the Cochrane Review 
0 =inapplicable 
Comment Reason for excluding a Cochrane Review/ we did 
not find the Cochrane Review 
If applicable type the comment 
0 =inapplicable 
Cochrane Review linked to a recommendation by 
the guideline 
If a Cochrane Review is in agreement with a 
specific recommendation made in the guideline 
0 = inapplicable (Cochrane Review 
excluded/withdrawn from publication) 
1 = yes 
2 = no 
Title of Cochrane Review found by us If a Cochrane Review is relevant to a guideline on 
basis of the name of the guideline or of a 
recommendation made in the guideline 
Copy the title of the Cochrane Review 
0 =inapplicable 
Number of Cochrane Review found by us If a Cochrane Review is relevant to a guideline on 
basis of the name of the guideline or of a 
recommendation made in the guideline 
Copy the number of the Cochrane Review 
0 =inapplicable 
Cochrane Review linked to a recommendation by 
us 
If a Cochrane Review is relevant to a 
recommendation in the guideline based on that 
recommendation 
0 = inapplicable (did not find the Cochrane 
Review) 
1 = yes 
2 = no  
Who found the Cochrane Review If the Cochrane Review is cited by the guideline or 
not. 
0 = inapplicable 
1 = the guideline as well  
2 = only the guideline 
3 = only we 
4 = only the guideline but excluded. E.g. 
pregnancy/adults only/withdrawn 
 
